Rheumatoid Arthritis

Showing NaN - NaN of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol
  • Palm Desert, California
  • +66 more
Mar 16, 2020

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol
  • Huntsville, Alabama
  • +120 more
Mar 16, 2020

Rheumatoid Arthritis Trial in Worldwide (PF-06650833, Placebo, Tofacitinib)

Completed
  • Rheumatoid Arthritis
  • Tuscaloosa, Alabama
  • +102 more
Feb 12, 2020

Rheumatoid Arthritis, Arthritis, Rheumatoid Trial in Worldwide (JHL1101, MabThera)

Terminated
  • Rheumatoid Arthritis
  • Arthritis, Rheumatoid
  • JHL1101
  • MabThera
  • Banja Luka, Bosnia and Herzegovina
  • +31 more
Jan 6, 2020

Rheumatoid Arthritis Trial in Worldwide (CKD-506, Placebo)

Completed
  • Rheumatoid Arthritis
  • Broumov, Czechia
  • +37 more
Dec 26, 2019

Rheumatoid Arthritis Trial in Worldwide (CP-690,550, Methotrexate, Placebo)

Completed
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +135 more
Nov 13, 2019

Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)

Completed
  • Rheumatoid Arthritis
  • Glendale, Arizona
  • +153 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Worldwide (Adalimumab, Baricitinib, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Glendale, Arizona
  • +212 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Worldwide (Placebo, Baricitinib, cDMARD)

Completed
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • Glendale, Arizona
  • +146 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Moscow (MabThera®, Ritumax®)

Terminated
  • Rheumatoid Arthritis
  • Moscow, Russian Federation
    Federal State Budgetary Institution "Scientific Research Institu
Jul 17, 2019

Rheumatoid Arthritis Trial in Worldwide (Etanercept, CHS-0214)

Completed
  • Rheumatoid Arthritis
  • Phoenix, Arizona
  • +140 more
Jun 7, 2019

Rheumatoid Arthritis Trial in Belarus, India, Russian Federation (BCD-055, Remicade®, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • BCD-055
  • +3 more
  • Minsk, Belarus
  • +38 more
Jun 12, 2019

Rheumatoid Arthritis Trial in Worldwide (BMS-986142, Placebo, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +103 more
May 2, 2019

Rheumatoid Arthritis Trial in Worldwide (Placebo, JNJ-38518168 (3 mg), JNJ-38518168 (10 mg))

Terminated
  • Rheumatoid Arthritis
  • Placebo
  • +4 more
  • Huntsville, Alabama
  • +86 more
Mar 13, 2019

Rheumatoid Arthritis Trial in Worldwide (Namilumab, Adalimumab, Methotrexate)

Terminated
  • Rheumatoid Arthritis
  • Pardubice, Czechia
  • +12 more
Aug 31, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-06410293, Adalimumab)

Completed
  • Rheumatoid Arthritis
  • PF-06410293
  • Adalimumab
  • Gilbert, Arizona
  • +182 more
Jan 18, 2019

Rheumatoid Arthritis Trial in Worldwide (PF-04171327, prednisone, )

Completed
  • Rheumatoid Arthritis
  • Tucson, Arizona
  • +92 more
Dec 12, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-04171327 10 mg, Prednisone Placebo, PF-04171327 25 mg)

Completed
  • Rheumatoid Arthritis
  • PF-04171327 10 mg
  • +5 more
  • Anniston, Alabama
  • +37 more
Nov 30, 2018

Rheumatoid Arthritis Trial in Worldwide (Remicade, Orencia, Ro-Actemra)

Completed
  • Rheumatoid Arthritis
  • Vienna, Austria
  • +8 more
Oct 30, 2018

Rheumatoid Arthritis Trial in Worldwide (GP2015)

Completed
  • Rheumatoid Arthritis
  • Peoria, Arizona
  • +91 more
Sep 18, 2018

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )

Terminated
  • Inflammation
  • Rheumatoid Arthritis
  • Huntington Beach, California
  • +139 more
Sep 3, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +326 more
May 11, 2018

Rheumatoid Arthritis Trial in Worldwide (PF-06438179, Infliximab)

Completed
  • Rheumatoid Arthritis
  • PF-06438179
  • Infliximab
  • Birmingham, Alabama
  • +183 more
Apr 30, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q4W, Placebo Q2W)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +200 more
May 11, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q2W, Placebo Q4W)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +233 more
May 4, 2018